Preferential binding of tumor suppressor p53 to positively or negatively supercoiled DNA involves the C-terminal domain

Journal of Molecular Biology

Volumn 292, Issue 2, 1999, Pages 241-249

  Mazur, Sharlyn J ^a   Sakaguchi, Kazuyasu ^b   Appella, Ettore ^b   Wang, Xin Wei ^b   Harris, Curtis C ^b   Bohr, Vilhelm A ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

C terminal domain; Negative supercoiling; p53; Positive supercoiling; Transcription

Indexed keywords

ANTIBODY; DNA; DNA TOPOISOMERASE; MUTANT PROTEIN; PROTEIN P53;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA SUPERCOILING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; STRUCTURE ACTIVITY RELATION;

EID: 0033578826     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1999.3064     Document Type: Article

References (56)

1. Agarwal M. L., Taylor W. R., Chernov M. V., Chernova O. B., Stark G. R. The p53 network. J. Biol. Chem. 273:1998;1-4.
2. Albor A., Kaku S., Kulesz-Martin M. Wild-type and mutant forms of p53 activate human topoisomerase I: a possible mechanism for gain of function in mutants. Cancer Res. 58:1998;2091-2094.
3. Almog N., Li R., Peled A., Schwartz D., Wolkowicz R., Goldfinger N., Pei H., Rotter V. The murine C′-terminally alternatively spliced form of p53 induces attenuated apoptosis in myeloid cells. Mol. Cell. Biol. 17:1997;713-722.
4. Anderson M. E., Woelker B., Reed M., Wang P., Tegtmeyer P. Reciprocal interference between the sequence-specific core and nonspecific C-terminal DNA binding domains of p53: implications for regulation. Mol. Cell. Biol. 17:1997;6255-6264.
5. Bakalkin G., Yakovleva T., Selivanova G., Magnusson K. P., Szekely L., Kiseleva E., Klein G., Terenius L., Wiman K. G. p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proc. Natl Acad. Sci. USA. 91:1994;413-417.
6. Bohr V. A., Smith C. A., Okumoto D. S., Hanawalt P. C. DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall. Cell. 40:1985;359-369.
7. Boulinkas T. DNA lesion-recognizing proteins and the p53 connection. Anticancer Res. 16:1996;225-242.
8. Clore G. M., Omichinski J. G., Sakaguchi K., Zambrano N., Sakamoto H., Appella E., Gronenborn A. M. High-resolution structure of the oligomerization domain of p53 by multidimensional NMR. Science. 265:1994;386-391.
9. Clore G. M., Omichinski J. G., Sakaguchi K., Zambrano N., Sakamoto H., Appella E., Gronenborn A. M. Interhelical angles in the solution structure of the oligomerization domain of p53: correction. Science. 267:1995;1515-1516.
10. Craig J. M., Boyle S., Perry P., Bickmore W. A. Scaffold attachments within the human genome. J. Cell Sci. 110:1997;2673-2682.
11. Dumaz N., Duthu A., Ehrhart J. C., Drougard C., Appella E., Anderson C. W., May P., Sarasin A., Daya-Grosjean L. Prolonged p53 protein accumulation in trichothiodystrophy fibroblasts dependent on unrepaired pyrimidine dimers on the transcribed strands of cellular genes. Mol. Carcin. 20:1997;340-347.
12. el-Deiry W. S., Kern S. E., Pietenpol J. A., Kinzler K. W., Vogelstein B. Definition of a consensus binding site for p53. Nature Genet. 1:1992;45-49.
13. Ford J. M., Hanawalt P. C. Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc. Natl Acad. Sci. USA. 92:1995;8876-8880.
14. Ford J. M., Baron E. L., Hanawalt P. C. Human fibroblasts expressing the human papillomavirus E6 gene are deficient in global genomic nucleotide excision repair and sensitive to ultraviolet irradiation. Cancer Res. 58:1998;599-603.
15. Friedberg E., Walker G., Siede W. DNA Repair and Mutagenesis. 1995;ASM Press, Washington DC.
16. Friedman P. N., Kern S. E., Vogelstein B., Prives C. Wild-type, but not mutant, human p53 proteins inhibit the replication activities of simian virus 40 large tumor antigen. Proc. Natl Acad. Sci. USA. 87:1990;9275-9279.
17. Giaccia A. J., Kastan M. B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12:1998;2973-2983.
18. Gobert C., Bracco L., Rossi F., Olivier M., Tazi J., Lavelle F., Larsen A. K., Riou J. F. Modulation of DNA topoisomerase I activity by p53. Biochemistry. 35:1996;5778-5786.
19. Gu W., Roeder R. G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell. 90:1997;595-606.
20. Harris C. C. p53: at the crossroads of molecular carcinogenesis and risk assessment. Science. 262:1993;1980-1981.
21. Harris C. C. Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J. Natl Cancer Inst. 88:1996;1442-1455.
22. Hollstein M., Sidransky D., Vogelstein B., Harris C. C. p53 mutations in human cancers. Science. 253:1991;49-53.
23. Hsu I. C., Metcalf R. A., Sun T., Welsh J. A., Wang N. J., Harris C. C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature. 350:1991;427-428.
24. Hupp T. R., Lane D. P. Regulation of the cryptic sequence-specific DNA-binding function of p53 by protein kinases. Cold Spring Harb. Symp. Quant. Biol. 59:1994;195-206.
25. Hupp T. R., Meek D. W., Midgley C. A., Lane D. P. Regulation of the specific DNA binding function of p53. Cell. 71:1992;875-886.
26. Jayaraman L., Freulich E., Prives C. Functional dissection of p53 tumor suppressor protein. Methods Enzymol. 283:1997;245-256.
27. Jeffrey P. D., Gorina S., Pavletich N. P. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science. 267:1995;1498-1502.
28. Kramer P. R., Sinden R. R. Measurement of unrestrained negative supercoiling and topological domain size in living human cells. Biochemistry. 36:1997;3151-3158.
29. LaMarr W. A., Sandman K. M., Reeve J. N., Dedon P. C. Large scale preparation of positively supercoiled DNA using the archaeal histone HMf. Nucl. Acids Res. 25:1997;1660-1661.
30. Lee S., Elenbaas B., Levine A., Griffith J. p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/ deletion mismatches. Cell. 81:1995;1013-1020.
31. Lee S., Cavallo L., Griffith J. Human p53 binds Holliday junctions strongly and facilitates their cleavage. J. Biol. Chem. 272:1997;7532-7539.
32. Levine A. J. p53, the cellular gatekeeper for growth and division. Cell. 88:1997;323-331.
33. Levine A. J., Momand J., Finlay C. A. The p53 tumour suppressor gene. Nature. 351:1991;453-456.
34. Lilley D. M., Chen D., Bowater R. P. DNA supercoiling and transcription: topological coupling of promoters. Quart. Rev. Biophys. 29:1996;203-225.
35. Linke S. P., Clarkin K. C., Di Leonardo A., Tsou A., Wahl G. M. A reversible, p53-dependent G0/G1 cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev. 10:1996;934-947.
36. Liu L. F., Wang J. C. Supercoiling of the DNA template during transcription. Proc. Natl Acad. Sci. USA. 84:1987;7024-7027.
37. Ljungman M., Zhang F. Blockage of RNA polymerase as a possible trigger for u.v. light-induced apoptosis. Oncogene. 13:1996;823-831.
38. Ljungman M., Zhang F., Chen. F., Rainbow A. J., McKay B. C. Inhibition of RNA polymerase II as a trigger for the p53 response. Oncogene. 18:1999;583-592.
39. McKay B. C., Ljungman M., Rainbow A. J. Persistent DNA damage induced by ultraviolet light inhibits p21waf1 and bax expression: implications for DNA repair, UV sensitivity and the induction of apoptosis. Oncogene. 17:1998;545-555.
40. Mellon I., Spivak G., Hanawalt P. C. Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell. 51:1987;241-249.
41. Michelotti G. A., Michelotti E. F., Pullner A., Duncan R. C., Eick D., Levens D. Multiple single-stranded cis elements are associated with activated chromatin of the human c-myc gene in vivo. Mol. Cell Biol. 16:1996;2656-2669.
42. Nelson W. G., Kastan M. B. DNA strand breaks: the DNA template alterations that trigger p53- dependent DNA damage response pathways. Mol. Cell Biol. 14:1994;1815-1823.
43. Paleček E., Vlk D., Stankova V., Brazda V., Vojtesek B., Hupp T. R., Schaper A., Jovin T. M. Tumor suppressor protein p53 binds preferentially to supercoiled DNA. Oncogene. 15:1997;2201-2209.
44. Polyak K., Xia Y., Zweier J. L., Kinzler K. W., Vogelstein B. A model for p53-induced apoptosis. Nature. 389:1997;300-305.
45. Reed M., Woelker B., Wang P., Wang Y., Anderson M. E., Tegtmeyer P. The C-terminal domain of p53 recognizes DNA damaged by ionizing radiation. Proc. Natl Acad. Sci. USA. 92:1995;9455-9459.
46. Sakaguchi K., Sakamoto H., Lewis M. S., Anderson C. W., Erickson J. W., Appella E., Xie D. Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry. 36:1997;10117-10124.
47. Sakaguchi K., Herrera J. E., Saito S., Miki T., Bustin M., Vassilev A., Anderson C. W., Appella E. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev. 12:1998;2831-2841.
48. Sakamoto H., Lewis M. S., Kodama H., Appella E., Sakaguchi K. Specific sequences from the carboxyl terminus of human p53 gene product form anti-parallel tetramers in solution. Proc. Natl Acad. Sci. USA. 91:1994;8974-8978.
49. Sambrook J., Frisch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
50. Szak S. T., Pietenpol J. A. High affinity insertion/deletion lesion binding by p53. J. Biol. Chem. 274:1999;3904-3909.
51. Unger T., Mietz J. A., Scheffner M., Yee C. L., Howley P. M. Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression. Mol. Cell Biol. 13:1993;5186-5194.
52. Wang X. W., Yeh H., Schaeffer L., Roy R., Moncollin V., Egly J. M., Wang Z., Freidberg E. C., Evans M. K., Taffe B. G. et al. p53 modulation of TFIIH-associated nucleotide excision repair activity. Nature Genet. 10:1995;188-195.
53. Wang Y., Reed M., Wang P., Stenger J. E., Mayr G., Anderson M. E., Schwedes J. F., Tegtmeyer P. p53 domains: identification and characterization of two autonomous DNA-binding regions. Genes Dev. 7:1993;2575-2586.
54. Yamaizumi M., Sugano T. U.V.-induced nuclear accumulation of p53 is evoked through DNA damage of actively transcribed genes independent of the cell cycle. Oncogene. 9:1994;2775-2784.
55. Zhou X., Wang X.-W., Xu L., Hagiwara K., Nagashima M., Wolkowicz R., Zurer I., Rotter V., Harris C. C. COOH-terminal domain of p53 modulates p53-mediated transcriptional transactivation, cell growth and apoptosis. Cancer Res. 59:1999;843-848.
56. Zlatanove J., van Holde K. Binding to four-way junction DNA: a common property of architectural proteins? FASEB J. 12:1998;421-431.